Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G ZUBROD

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
National Cancer Institute Monograph|March 1, 1977
Drug development in the United States and U.S.S.R.: commentary on the cooperative accomplishmentsC G Zubrod, N N Blokhin
Cancer Chemotherapy Reports|November 1, 1973
Adjuvant temperature effects in cancer therapyJ B Block, C G Zubrod
Federation Proceedings|November 11, 2010
A mechanism of drug potentiation; pamaquin metabolism as influenced by quinacrineT J KENNEDY, C G ZUBROD
Cancer Research|June 1, 1983
Correlation of in vitro clonogenic assay data with in vivo growth delays and cell cycle changes of a human melanoma xenograftV Gupta, A Krishan, C G Zubrod
Federation Proceedings|November 11, 2010
Methemalbuminemia during combined therapy with pamaquine and quinineW D BLAKE, C G ZUBROD, M ROSENFELD
National Cancer Institute Monograph|March 1, 1977
The linear arrayC G Zubrod, S A Schepartz, S K Carter
National Cancer Institute Monograph|March 1, 1977
Historical background of the National Cancer Institute's drug development thrustC G Zubrod, S A Schepartz, S K Carter
Cancer|March 15, 1989
Activity of pirarubicin (4'-0-tetrahydropyranyladriamycin) in malignant mesotheliomaK S Sridhar, A M Hussein, L G Feun, et al.
Cancer Research|March 1, 1980
Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivoR Ganapathi, A Krishan, I Wodinsky, et al.
The New England Journal of Medicine|November 20, 1975
Letter: Cerebral metastases and carcinoembryonic antigen in CSFL S Snitzer, E C McKinney, F Tejada, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
National Cancer Institute Monograph|March 1, 1977
Drug development in the United States and U.S.S.R.: commentary on the cooperative accomplishmentsC G Zubrod, N N Blokhin
Cancer Chemotherapy Reports|November 1, 1973
Adjuvant temperature effects in cancer therapyJ B Block, C G Zubrod
Federation Proceedings|November 11, 2010
A mechanism of drug potentiation; pamaquin metabolism as influenced by quinacrineT J KENNEDY, C G ZUBROD
Cancer Research|June 1, 1983
Correlation of in vitro clonogenic assay data with in vivo growth delays and cell cycle changes of a human melanoma xenograftV Gupta, A Krishan, C G Zubrod
Federation Proceedings|November 11, 2010
Methemalbuminemia during combined therapy with pamaquine and quinineW D BLAKE, C G ZUBROD, M ROSENFELD
National Cancer Institute Monograph|March 1, 1977
The linear arrayC G Zubrod, S A Schepartz, S K Carter
National Cancer Institute Monograph|March 1, 1977
Historical background of the National Cancer Institute's drug development thrustC G Zubrod, S A Schepartz, S K Carter
Cancer|March 15, 1989
Activity of pirarubicin (4'-0-tetrahydropyranyladriamycin) in malignant mesotheliomaK S Sridhar, A M Hussein, L G Feun, et al.
Cancer Research|March 1, 1980
Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivoR Ganapathi, A Krishan, I Wodinsky, et al.
The New England Journal of Medicine|November 20, 1975
Letter: Cerebral metastases and carcinoembryonic antigen in CSFL S Snitzer, E C McKinney, F Tejada, et al.
Pageof 3